National Institute on Minority Health and Health Disparities; Notice of Meeting, 26574-26575 [2015-11062]
Download as PDF
asabaliauskas on DSK5VPTVN1PROD with NOTICES
26574
Federal Register / Vol. 80, No. 89 / Friday, May 8, 2015 / Notices
Name of Committee: Bioengineering
Sciences & Technologies Integrated Review
Group, Nanotechnology Study Section.
Date: June 4–5, 2015.
Time: 7:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Los Angeles Airport Marriott, 5855
West Century Boulevard, Los Angeles, CA
90045.
Contact Person: James J Li, Ph.D., Scientific
Review Officer, Center for Scientific Review,
National Institutes of Health, 6701 Rockledge
Drive, Room 5148, MSC 7849, Bethesda, MD
20892, 301–806–8065, lijames@csr.nih.gov.
Name of Committee: Cell Biology
Integrated Review Group, Membrane Biology
and Protein Processing Study Section.
Date: June 4–5, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Nikko San Francisco, 222
Mason Street, San Francisco, CA 94102.
Contact Person: Janet M Larkin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142,
MSC 7840, Bethesda, MD 20892, 301–806–
2765, larkinja@csr.nih.gov.
Name of Committee: Musculoskeletal, Oral
and Skin Sciences Integrated Review Group,
Skeletal Biology Development and Disease
Study Section.
Date: June 4–5, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th Street, Washington, DC
20001.
Contact Person: Aruna K Behera, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4211,
MSC 7814, Bethesda, MD 20892, 301–435–
6809, beheraak@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group, Drug Discovery and Molecular
Pharmacology Study Section.
Date: June 4–5, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Marriott Wardman Park Washington
DC Hotel, 2660 Woodley Road NW.,
Washington, DC 20008.
Contact Person: Jeffrey Smiley, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6194,
MSC 7804, Bethesda, MD 20892, 301–594–
7945, smileyja@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
VerDate Sep<11>2014
16:38 May 07, 2015
Jkt 235001
Dated: May 1, 2015.
Anna Snouffer,
Deputy Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–11065 Filed 5–7–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Center for Advancing
Translational Sciences; Notice of
Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of meetings of the National
Center for Advancing Translational
Sciences.
The meetings will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cures Acceleration
Network Review Board.
Date: June 18, 2015.
Time: 8:30 a.m. to 3:00 p.m.
Agenda: Report from the Institute Director.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Danilo A Tagle, Ph.D.,
Executive Secretary, National Center for
Advancing Translational Sciences, 1
Democracy Plaza, Room 992, Bethesda, MD
20892, 301–594–8064, Danilo.Tagle@nih.gov.
Name of Committee: National Center for
Advancing Translational Sciences Advisory
Council.
Date: June 18, 2015.
Open: 8:30 a.m. to 3:00 p.m.
Agenda: Report from the Institute Director
and other staff.
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Closed: 3:15 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Place: National Institutes of Health,
Building 31, Conference Room 10, 31 Center
Drive, Bethesda, MD 20892.
Contact Person: Danilo A Tagle, Ph.D.,
Executive Secretary, National Center for
Advancing Translational Sciences, 1
Democracy Plaza, Room 992, Bethesda, MD
20892, 301–594–8064, Danilo.Tagle@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.350, B—Cooperative
Agreements; 93.859, Biomedical Research
and Research Training, National Institutes of
Health, HHS)
Dated: May 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–11064 Filed 5–7–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health
and Health Disparities; Notice of
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of a meeting of the
National Advisory Council on Minority
Health and Health Disparities.
The meeting will be open to the
public as indicated below, with
attendance limited to space available.
Individuals who plan to attend and
need special assistance, such as sign
language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications
and/or contract proposals and the
discussions could disclose confidential
trade secrets or commercial property
such as patentable material, and
personal information concerning
individuals associated with the grant
applications and/or contract proposals,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Advisory
Council on Minority Health and Health
Disparities.
Date: June 9, 2015.
Open: 8:30 a.m. to 03:00 p.m.
Agenda: The agenda will include opening
remarks, administrative matters, Director’s
Report, NIH Health Disparities update, and
other business of the Council.
E:\FR\FM\08MYN1.SGM
08MYN1
Federal Register / Vol. 80, No. 89 / Friday, May 8, 2015 / Notices
Place: National Institutes of Health, 31
Center Drive, Building 31, Conference Room
6, Bethesda, MD 20892.
Closed: 03:00 p.m. to Adjournment.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 31
Center Drive, Building 31, Conference Room
6, Bethesda, MD 20892.
Contact Person: Donna Brooks, Executive
Officer, National Institutes of Health,
National Institute on Minority Health and
Heath Disparities, 6707 Democracy Blvd.,
Suite 800, Bethesda, MD 20892, (301) 435–
2135, brooksd@mail.nih.gov.
Any member of the public interested
in presenting oral comments to the
committee may notify the Contact
Person listed on this notice at least 10
days in advance of the meeting.
Interested individuals and
representatives of organizations may
submit a letter of intent, a brief
description of the organization
represented, and a short description of
the oral presentation. Only one
representative of an organization may be
allowed to present oral comments and if
accepted by the committee,
presentations may be limited to five
minutes. Both printed and electronic
copies are requested for the record. In
addition, any interested person may file
written comments with the committee
by forwarding their statement to the
Contact Person listed on this notice. The
statement should include the name,
address, telephone number and when
applicable, the business or professional
affiliation of the interested person.
In the interest of security, NIH has
instituted stringent procedures for
entrance onto the NIH campus. All
visitor vehicles, including taxis, hotel,
and airport shuttles, will be inspected
before being allowed on campus.
Visitors will be asked to show one form
of identification (for example, a
government-issued photo ID, driver’s
license, or passport) and to state the
purpose of their visit.
Dated: May 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–11062 Filed 5–7–15; 8:45 am]
BILLING CODE 4140–01–P
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Biomedical Imaging and Bioengineering
Special Emphasis Panel, SBIR Contract
Review.
Date: June 17, 2015.
Time: 12:00 p.m. to 3:30 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Institutes of Health, Two
Democracy Plaza, Suite 920, 6707 Democracy
Boulevard, Bethesda, MD 20892, (Virtual
Meeting).
Contact Person: Dennis Hlasta, Ph.D.,
Scientific Review Officer, 6707 Democracy
Boulevard, Suite 952, Bethesda, MD 20892,
301–451–4794, hlastadj@mail.nih.gov.
Dated: May 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–11063 Filed 5–7–15; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Substance Abuse and Mental Health
Services Administration
Announcement of Requirements and
Registration for the Opioid Overdose
Prevention Challenge
SAMHSA, HHS.
Notice.
AGENCY:
ACTION:
Authority: 15 U.S.C. 3719.
In summarizing the challenge
that will be issued by your agency,
please answer the following four
questions:
SUMMARY:
asabaliauskas on DSK5VPTVN1PROD with NOTICES
(1) What action is being taken?
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Biomedical
Imaging and Bioengineering; Notice of
Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
VerDate Sep<11>2014
16:38 May 07, 2015
Jkt 235001
The Substance Abuse and Mental
Health Services Administration
(SAMHSA) has issued a challenge to
help prevent opioid overdose and
support recovery through innovative,
software-based solutions that help
people know the signs of opioid use,
understand what to do if a family
member or friend overdoses on heroin
or opioid pain medications, and support
PO 00000
Frm 00054
Fmt 4703
Sfmt 4703
26575
treatment for opioid addiction and
recovery.
(2) Why is this action necessary?
There were 17,000 deaths from
opioids in 2010, double the deaths in
2001. Use of prescription opioids has
quadrupled. Death by opioid overdose is
preventable. SAMHSA hopes to help
prevent deaths from opioid overdose,
and support treatment and recovery for
individuals with an opioid substance
use disorder.
(3) What is the objective of the
challenge?
To prevent deaths from opioid
overdose, and support treatment and
recovery for individuals with an opioid
substance use disorder by providing
resources and information on
understanding the signs of overdose,
how to respond to an overdose,
information about opioid use, treatment,
and recovery.
(4) What is the intended effect of this
action?
A reduction in the number of
individuals dying from opioid overdose.
SAMHSA is seeking solutions to this
problem through cost-effective, portable,
technology-based products that
effectively reach a diverse population of
friends and family concerned about
opioid use by someone they know.
Technology-based products may
include, but are not limited to, web
applications, mobile apps, and Web
sites.
The challenge starts on June 1,
2015 10:00 a.m. ET. The challenge ends
on July 29, 2015 11:59 p.m. ET.
FOR FURTHER INFORMATION CONTACT: Dina
Passman, Public Health Advisor,
SAMHSA/CSAT/PMB, 1 Choke Cherry
Road, Room 5–1070, Rockville, MD,
Phone: (240) 276–2854, Email:
Dina.Passman@samhsa.hhs.gov.
SUPPLEMENTARY INFORMATION:
Subject of Challenge Competition:
Opioid Overdose Prevention.
Eligibility Rules for Participating in
the Competition:
To satisfy the mandatory provisions of
the Competes Act, use the following
language:
‘‘To be eligible to win a prize under
this challenge, an individual or entity—
(1) Shall have registered to participate
in the competition under the rules
promulgated by [the issuing agency];
(2) Shall have complied with all the
requirements under this section;
(3) In the case of a private entity, shall
be incorporated in and maintain a
primary place of business in the United
States, and in the case of an individual,
DATES:
E:\FR\FM\08MYN1.SGM
08MYN1
Agencies
[Federal Register Volume 80, Number 89 (Friday, May 8, 2015)]
[Notices]
[Pages 26574-26575]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-11062]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute on Minority Health and Health Disparities;
Notice of Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of a meeting of the
National Advisory Council on Minority Health and Health Disparities.
The meeting will be open to the public as indicated below, with
attendance limited to space available. Individuals who plan to attend
and need special assistance, such as sign language interpretation or
other reasonable accommodations, should notify the Contact Person
listed below in advance of the meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and/or contract proposals
and the discussions could disclose confidential trade secrets or
commercial property such as patentable material, and personal
information concerning individuals associated with the grant
applications and/or contract proposals, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Advisory Council on Minority Health
and Health Disparities.
Date: June 9, 2015.
Open: 8:30 a.m. to 03:00 p.m.
Agenda: The agenda will include opening remarks, administrative
matters, Director's Report, NIH Health Disparities update, and other
business of the Council.
[[Page 26575]]
Place: National Institutes of Health, 31 Center Drive, Building
31, Conference Room 6, Bethesda, MD 20892.
Closed: 03:00 p.m. to Adjournment.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 31 Center Drive, Building
31, Conference Room 6, Bethesda, MD 20892.
Contact Person: Donna Brooks, Executive Officer, National
Institutes of Health, National Institute on Minority Health and
Heath Disparities, 6707 Democracy Blvd., Suite 800, Bethesda, MD
20892, (301) 435-2135, brooksd@mail.nih.gov.
Any member of the public interested in presenting oral comments to
the committee may notify the Contact Person listed on this notice at
least 10 days in advance of the meeting. Interested individuals and
representatives of organizations may submit a letter of intent, a brief
description of the organization represented, and a short description of
the oral presentation. Only one representative of an organization may
be allowed to present oral comments and if accepted by the committee,
presentations may be limited to five minutes. Both printed and
electronic copies are requested for the record. In addition, any
interested person may file written comments with the committee by
forwarding their statement to the Contact Person listed on this notice.
The statement should include the name, address, telephone number and
when applicable, the business or professional affiliation of the
interested person.
In the interest of security, NIH has instituted stringent
procedures for entrance onto the NIH campus. All visitor vehicles,
including taxis, hotel, and airport shuttles, will be inspected before
being allowed on campus. Visitors will be asked to show one form of
identification (for example, a government-issued photo ID, driver's
license, or passport) and to state the purpose of their visit.
Dated: May 4, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-11062 Filed 5-7-15; 8:45 am]
BILLING CODE 4140-01-P